MoneyWorks4Me

Smruthi Organics - Quaterly Results

27 Jul 2024 Evaluate
Net sales declined -21.88%  to  Rs. 272.73 million from Rs. 349.12 millions.The Net Loss for the quarter ended June 2024 is Rs. -9.22 millions as compared to Net Profit of Rs. 22.94 millions of corresponding quarter ended June 2023Operating Profit reported a sharp decline to 4.48 millions from 46.29 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 272.73 349.12 -21.88 272.73 349.12 -21.88 1276.43 1410.41 -9.50
Other Income 0.02 0.11 -81.82 0.02 0.11 -81.82 0.76 1.07 -28.97
PBIDT 4.48 46.29 -90.32 4.48 46.29 -90.32 120.31 98.87 21.69
Interest 4.08 3.25 25.54 4.08 3.25 25.54 14.08 8.22 71.29
PBDT 0.40 43.04 -99.07 0.40 43.04 -99.07 106.23 90.65 17.19
Depreciation 12.94 12.38 4.52 12.94 12.38 4.52 56.53 45.72 23.64
PBT -12.54 30.66 -140.90 -12.54 30.66 -140.90 49.70 44.93 10.62
TAX -3.32 7.72 -143.01 -3.32 7.72 -143.01 13.79 3.63 279.89
Deferred Tax -3.32 -1.13 193.81 -3.32 -1.13 193.81 -2.27 -10.97 -79.31
PAT -9.22 22.94 -140.19 -9.22 22.94 -140.19 35.91 41.30 -13.05
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 1.64 13.26 -87.61 1.64 13.26 -87.61 9.43 7.01 34.46
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..